Concepedia

Publication | Open Access

Longterm Safety and Efficacy of Adalimumab and Infliximab for Uveitis Associated with Juvenile Idiopathic Arthritis

DOIFull Paper Access

67

Citations

10

References

2018

Year

Vanessa Cecchin, Maria Elisabetta Zannin, Daniele Ferrari, Irene Pontikaki, Elisabetta Miserocchi, Maria Pia Paroli, Claudia Bracaglia, Denise Pires Marafon, Serena Pastore, Fulvio Parentin,
The Journal of Rheumatology

Abstract

At the 2-year followup, ADA showed a better efficacy and safety profile than IFX for the treatment of refractory JIA-associated uveitis.

References

YearCitations

Page 1